Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study - 14/12/17

Timothy H. Schmidt, MD, PhD ^a, Jean-Phillip Okhovat, MD, MPH ^{b, c}, Keshav Khanijow, MD ^d, Heather Huddleston, MD ^e, Marcelle Cedars, MD ^e, Lauri Pasch, PhD ^f, Erica T. Wang, MD, MAS ^g, Julie Lee, MD ^h, Kanade Shinkai, MD, PhD ^{a, ⁎}

^a Department of Dermatology, University of California San Francisco, San Francisco, California 

^e Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, California 

^f Department of Psychiatry, University of California San Francisco, San Francisco, California 

^b Harvard T. H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 

^c Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 

^d Department of Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 

^g Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California 

^h School of Medicine, University of California San Diego, San Diego, California 

^∗Reprint requests: Kanade Shinkai, MD, PhD, Associate Professor of Clinical Dermatology, UCSF Department of Dermatology, 1701 Divisadero St, 3rd fl, San Francisco, CA 94115.Associate Professor of Clinical DermatologyUCSF Department of Dermatology1701 Divisadero St3rd flSan FranciscoCA94115